schliessen

Filtern

 

Bibliotheken

Oncogenic and RASopathy-associated K-RAS mutations relieve membrane-dependent occlusion of the effector-binding site.

K-RAS4B (Kirsten rat sarcoma viral oncogene homolog 4B) is a prenylated, membrane-associated GTPase protein that is a critical switch for the propagation of growth factor signaling pathways to diverse effector proteins, including rapidly accelerated fibrosarcoma (RAF) kinases and RAS-related protein... Full description

Journal Title: Proceedings of the National Academy of Sciences of the United States of America May 26, 2015, Vol.112(21), pp.6625-6630
Main Author: Mazhab-Jafari, Mohammad T
Other Authors: Marshall, Christopher B , Smith, Matthew J , Gasmi-Seabrook, Geneviève M C , Stathopulos, Peter B , Inagaki, Fuyuhiko , Kay, Lewis E , Neel, Benjamin G , Ikura, Mitsuhiko
Format: Electronic Article Electronic Article
Language: English
Subjects:
ID: E-ISSN: 1091-6490 ; DOI: 10.1073/pnas.1419895112
Link: http://search.proquest.com/docview/1683755449/?pq-origsite=primo
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: proquest1683755449
title: Oncogenic and RASopathy-associated K-RAS mutations relieve membrane-dependent occlusion of the effector-binding site.
format: Article
creator:
  • Mazhab-Jafari, Mohammad T
  • Marshall, Christopher B
  • Smith, Matthew J
  • Gasmi-Seabrook, Geneviève M C
  • Stathopulos, Peter B
  • Inagaki, Fuyuhiko
  • Kay, Lewis E
  • Neel, Benjamin G
  • Ikura, Mitsuhiko
subjects:
  • Amino Acid Sequence–Genetics
  • Binding Sites–Chemistry
  • Genes, Ras–Genetics
  • Humans–Metabolism
  • Lipid Bilayers–Chemistry
  • Models, Molecular–Genetics
  • Molecular Dynamics Simulation–Metabolism
  • Molecular Sequence Data–Metabolism
  • Mutation–Metabolism
  • Nuclear Magnetic Resonance, Biomolecular–Metabolism
  • Protein Conformation–Metabolism
  • Protein Interaction Domains and Motifs–Metabolism
  • Proto-Oncogene Proteins P21(Ras)–Metabolism
  • Sequence Homology, Amino Acid–Metabolism
  • Signal Transduction–Metabolism
  • Static Electricity–Metabolism
  • Ral Guanine Nucleotide Exchange Factor–Metabolism
  • Lipid Bilayers
  • Ral Guanine Nucleotide Exchange Factor
  • K-Ras4b Protein, Human
  • Proto-Oncogene Proteins P21(Ras)
  • Kras
  • Noonan Syndrome
  • Lipid Bilayer Nanodisc
  • Nuclear Magnetic Resonance
  • Oncogenic Mutation
ispartof: Proceedings of the National Academy of Sciences of the United States of America, May 26, 2015, Vol.112(21), pp.6625-6630
description: K-RAS4B (Kirsten rat sarcoma viral oncogene homolog 4B) is a prenylated, membrane-associated GTPase protein that is a critical switch for the propagation of growth factor signaling pathways to diverse effector proteins, including rapidly accelerated fibrosarcoma (RAF) kinases and RAS-related protein guanine nucleotide dissociation stimulator (RALGDS) proteins. Gain-of-function KRAS mutations occur frequently in human cancers and predict poor clinical outcome, whereas germ-line mutations are associated with developmental syndromes. However, it is not known how these mutations affect K-RAS association with biological membranes or whether this impacts signal transduction. Here, we used solution NMR studies of K-RAS4B tethered to nanodiscs to investigate lipid bilayer-anchored K-RAS4B and its interactions with effector protein RAS-binding domains (RBDs). Unexpectedly, we found that the effector-binding region of activated K-RAS4B is occluded by interaction with the membrane in one of the NMR-observable, and thus highly populated, conformational states. Binding of the RAF isoform ARAF and RALGDS RBDs induced marked reorientation of K-RAS4B from the occluded state to RBD-specific effector-bound states. Importantly, we found that two Noonan syndrome-associated mutations, K5N and D153V, which do not affect the GTPase cycle, relieve the occluded orientation by directly altering the electrostatics of two membrane interaction surfaces. Similarly, the most frequent KRAS oncogenic mutation G12D also drives K-RAS4B toward an exposed configuration. Further, the D153V and G12D mutations increase the rate of association of ARAF-RBD with lipid bilayer-tethered K-RAS4B. We revealed a mechanism of K-RAS4B autoinhibition by membrane sequestration of its effector-binding site, which can be disrupted by disease-associated mutations. Stabilizing the autoinhibitory interactions between K-RAS4B and the membrane could be an attractive target for anticancer drug discovery.
language: eng
source:
identifier: E-ISSN: 1091-6490 ; DOI: 10.1073/pnas.1419895112
fulltext: fulltext
issn:
  • 10916490
  • 1091-6490
url: Link


@attributes
ID1025315921
RANK0.07
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordid1683755449
sourceidproquest
recordidTN_proquest1683755449
sourcesystemPC
pqid1683755449
galeid433686879
display
typearticle
titleOncogenic and RASopathy-associated K-RAS mutations relieve membrane-dependent occlusion of the effector-binding site.
creatorMazhab-Jafari, Mohammad T ; Marshall, Christopher B ; Smith, Matthew J ; Gasmi-Seabrook, Geneviève M C ; Stathopulos, Peter B ; Inagaki, Fuyuhiko ; Kay, Lewis E ; Neel, Benjamin G ; Ikura, Mitsuhiko
contributorMazhab-Jafari, Mohammad T (correspondence author) ; Mazhab-Jafari, Mohammad T (record owner)
ispartofProceedings of the National Academy of Sciences of the United States of America, May 26, 2015, Vol.112(21), pp.6625-6630
identifierE-ISSN: 1091-6490 ; DOI: 10.1073/pnas.1419895112
subjectAmino Acid Sequence–Genetics ; Binding Sites–Chemistry ; Genes, Ras–Genetics ; Humans–Metabolism ; Lipid Bilayers–Chemistry ; Models, Molecular–Genetics ; Molecular Dynamics Simulation–Metabolism ; Molecular Sequence Data–Metabolism ; Mutation–Metabolism ; Nuclear Magnetic Resonance, Biomolecular–Metabolism ; Protein Conformation–Metabolism ; Protein Interaction Domains and Motifs–Metabolism ; Proto-Oncogene Proteins P21(Ras)–Metabolism ; Sequence Homology, Amino Acid–Metabolism ; Signal Transduction–Metabolism ; Static Electricity–Metabolism ; Ral Guanine Nucleotide Exchange Factor–Metabolism ; Lipid Bilayers ; Ral Guanine Nucleotide Exchange Factor ; K-Ras4b Protein, Human ; Proto-Oncogene Proteins P21(Ras) ; Kras ; Noonan Syndrome ; Lipid Bilayer Nanodisc ; Nuclear Magnetic Resonance ; Oncogenic Mutation
languageeng
source
descriptionK-RAS4B (Kirsten rat sarcoma viral oncogene homolog 4B) is a prenylated, membrane-associated GTPase protein that is a critical switch for the propagation of growth factor signaling pathways to diverse effector proteins, including rapidly accelerated fibrosarcoma (RAF) kinases and RAS-related protein guanine nucleotide dissociation stimulator (RALGDS) proteins. Gain-of-function KRAS mutations occur frequently in human cancers and predict poor clinical outcome, whereas germ-line mutations are associated with developmental syndromes. However, it is not known how these mutations affect K-RAS association with biological membranes or whether this impacts signal transduction. Here, we used solution NMR studies of K-RAS4B tethered to nanodiscs to investigate lipid bilayer-anchored K-RAS4B and its interactions with effector protein RAS-binding domains (RBDs). Unexpectedly, we found that the effector-binding region of activated K-RAS4B is occluded by interaction with the membrane in one of the NMR-observable, and thus highly populated, conformational states. Binding of the RAF isoform ARAF and RALGDS RBDs induced marked reorientation of K-RAS4B from the occluded state to RBD-specific effector-bound states. Importantly, we found that two Noonan syndrome-associated mutations, K5N and D153V, which do not affect the GTPase cycle, relieve the occluded orientation by directly altering the electrostatics of two membrane interaction surfaces. Similarly, the most frequent KRAS oncogenic mutation G12D also drives K-RAS4B toward an exposed configuration. Further, the D153V and G12D mutations increase the rate of association of ARAF-RBD with lipid bilayer-tethered K-RAS4B. We revealed a mechanism of K-RAS4B autoinhibition by membrane sequestration of its effector-binding site, which can be disrupted by disease-associated mutations. Stabilizing the autoinhibitory interactions between K-RAS4B and the membrane could be an attractive target for anticancer drug discovery.
version11
lds50peer_reviewed
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
backlink$$Uhttp://search.proquest.com/docview/1683755449/?pq-origsite=primo$$EView_record_in_ProQuest_(subscribers_only)
search
creatorcontrib
0Mazhab-Jafari, Mohammad T
1Marshall, Christopher B
2Smith, Matthew J
3Gasmi-Seabrook, Geneviève M C
4Stathopulos, Peter B
5Inagaki, Fuyuhiko
6Kay, Lewis E
7Neel, Benjamin G
8Ikura, Mitsuhiko
titleOncogenic and RASopathy-associated K-RAS mutations relieve membrane-dependent occlusion of the effector-binding site.
subject
0Amino Acid Sequence–Genetics
1Binding Sites–Chemistry
2Genes, Ras–Genetics
3Humans–Metabolism
4Lipid Bilayers–Chemistry
5Models, Molecular–Genetics
6Molecular Dynamics Simulation–Metabolism
7Molecular Sequence Data–Metabolism
8Mutation–Metabolism
9Nuclear Magnetic Resonance, Biomolecular–Metabolism...
102MSE
112MSD
122MSC
13PDB
14KRAS
15Noonan syndrome
16lipid bilayer nanodisc
17nuclear magnetic resonance
18oncogenic mutation
general
0English
110.1073/pnas.1419895112
2MEDLINE (ProQuest)
3ProQuest Biological Science Collection
4ProQuest Natural Science Collection
5ProQuest SciTech Collection
6Biological Science Database
7Natural Science Collection
8SciTech Premium Collection
9Health Research Premium Collection
10Health Research Premium Collection (Alumni edition)
11Biological Science Index (ProQuest)
sourceidproquest
recordidproquest1683755449
issn
010916490
11091-6490
rsrctypearticle
creationdate2015
addtitleProceedings of the National Academy of Sciences of the United States of America
searchscope
01007527
11007944
21009130
310000004
410000038
510000050
610000120
710000159
810000238
910000253
1010000260
1110000270
1210000271
1310000302
1410000350
15proquest
scope
01007527
11007944
21009130
310000004
410000038
510000050
610000120
710000159
810000238
910000253
1010000260
1110000270
1210000271
1310000302
1410000350
15proquest
lsr43
01007527false
11007944false
21009130false
310000004false
410000038false
510000050false
610000120false
710000159false
810000238false
910000253false
1010000260false
1110000270false
1210000271false
1310000302false
1410000350false
contributorMazhab-Jafari, Mohammad T
startdate20150526
enddate20150526
citationpf 6625 pt 6630 vol 112 issue 21
lsr30VSR-Enriched:[description, galeid, issn, pqid]
sort
titleOncogenic and RASopathy-associated K-RAS mutations relieve membrane-dependent occlusion of the effector-binding site.
authorMazhab-Jafari, Mohammad T ; Marshall, Christopher B ; Smith, Matthew J ; Gasmi-Seabrook, Geneviève M C ; Stathopulos, Peter B ; Inagaki, Fuyuhiko ; Kay, Lewis E ; Neel, Benjamin G ; Ikura, Mitsuhiko
creationdate20150526
lso0120150526
facets
frbrgroupid3875390168346250556
frbrtype5
newrecords20181218
languageeng
creationdate2015
topic
0Amino Acid Sequence–Genetics
1Binding Sites–Chemistry
2Genes, Ras–Genetics
3Humans–Metabolism
4Lipid Bilayers–Chemistry
5Models, Molecular–Genetics
6Molecular Dynamics Simulation–Metabolism
7Molecular Sequence Data–Metabolism
8Mutation–Metabolism
9Nuclear Magnetic Resonance, Biomolecular–Metabolism...
collection
0MEDLINE (ProQuest)
1ProQuest Biological Science Collection
2ProQuest Natural Science Collection
3ProQuest SciTech Collection
4Biological Science Database
5Natural Science Collection
6SciTech Premium Collection
7Health Research Premium Collection
8Health Research Premium Collection (Alumni edition)
9Biological Science Index (ProQuest)
prefilterarticles
rsrctypearticles
creatorcontrib
0Mazhab-Jafari, Mohammad T
1Marshall, Christopher B
2Smith, Matthew J
3Gasmi-Seabrook, Geneviève M C
4Stathopulos, Peter B
5Inagaki, Fuyuhiko
6Kay, Lewis E
7Neel, Benjamin G
8Ikura, Mitsuhiko
jtitleProceedings of the National Academy of Sciences of the United States of America
toplevelpeer_reviewed
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
aulast
0Mazhab-Jafari
1Marshall
2Smith
3Gasmi-Seabrook
4Stathopulos
5Inagaki
6Kay
7Neel
8Ikura
aufirst
0Mohammad T
1Christopher B
2Matthew J
3Geneviève M C
4Peter B
5Fuyuhiko
6Lewis E
7Benjamin G
8Mitsuhiko
au
0Mazhab-Jafari, Mohammad T
1Marshall, Christopher B
2Smith, Matthew J
3Gasmi-Seabrook, Geneviève M C
4Stathopulos, Peter B
5Inagaki, Fuyuhiko
6Kay, Lewis E
7Neel, Benjamin G
8Ikura, Mitsuhiko
addauMazhab-Jafari, Mohammad T
atitleOncogenic and RASopathy-associated K-RAS mutations relieve membrane-dependent occlusion of the effector-binding site.
jtitleProceedings of the National Academy of Sciences of the United States of America
risdate20150526
volume112
issue21
spage6625
epage6630
pages6625-6630
eissn1091-6490
formatjournal
genrearticle
ristypeJOUR
doi10.1073/pnas.1419895112
urlhttp://search.proquest.com/docview/1683755449/
issn00278424
date2015-05-26